Cherry Creek Investment Advisors, Inc.

Position in JNJ — Johnson & Johnson

CIK 1877829 ENGLEWOOD, CO

Position in JNJ

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$281,398

+$33,292 QoQ

Shares Held

1,108

+9.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#4,219

of 4,664 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cherry Creek Investment Advisors, Inc. holds $9,772,035 across 6 Drug Manufacturers - General names. JNJ ranks #5 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	27,564	$6,936,204
2	GILD	Gilead Sciences, Inc.	8,954	$1,131,248
3	PFE	Pfizer Inc	24,153	$581,604
4	BMY	Bristol Myers Squibb Co	9,754	$562,025
5	JNJ	Johnson & Johnson This page	1,108	$281,398
6	AMGN	Amgen Inc	772	$279,556

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$281,398	1,108	+9.2%	Shares	Sole	2026-07-30
2026-03-31	$248,106	1,015	+1.0%	Shares	Sole	2026-04-30
2025-12-31	$207,984	1,005	—	Shares	Sole	2026-01-15
No filing history on record for this holder in this stock.